glp-1 in type 2 diabetes for Weight Loss and Clinical Focus on GLP-1 Agonists
Description
Are you feeding your gut properly
How long should I continue NAD+ therapy
GLP-1 Receptor Agonists and Pancreatic Safety Concerns in Type 2 Diabetic Patients: Data From Cardiovascular Outcome Trials
veterans with type 2 diabetes found that GLP-1s were associated with lower risk of developing substance use disorders (SUDs) involving alcohol, cannabis, cocaine, nicotine or opioids
Tanaka T, Higashijima Y, Wada T, et al
However, in the long-term, intrinsic -cell function shows minimal improvement despite clinical diabetes remission post-MBS, with progressive diminished function over time [31]
